Theriva Biologics, Inc. (TOVX) › Shares OutstandingTheriva Biologics, Inc. (TOVX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 23.34M2011: 31.29M2012: 44.36M2013: 58.21M2014: 72.51M2015: 90.83M2016: 117.17M2017: 3.67M2018: 15.48M2019: 16.81M2020: 29.25M2021: 13.20M2022: 15.12M2023: 686.2K2024: 2.78M2025: 35.69M35.69M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202535.69M+1182.6%20242.78M+305.5%2023686.2K-95.5%202215.12M+14.5%202113.20M-54.9%202029.25M+74.0%201916.81M+8.6%201815.48M+321.7%20173.67M-96.9%2016117.17M+29.0%201590.83M+25.3%201472.51M+24.6%201358.21M+31.2%201244.36M+41.8%201131.29M+34.1%201023.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share